| Literature DB >> 25154812 |
Catherine Alix-Panabières1, Klaus Pantel2.
Abstract
During the past ten years, circulating tumour cells (CTCs) have received enormous attention as new biomarkers and the subject of basic research. Although CTCs are already used in numerous clinical trials, their clinical utility is still under investigation. Many issues regarding the detection and characterization of CTCs remain unknown. In this Opinion article, we propose a conceptual framework of CTC assays and point out current challenges of CTC research, which might structure this dynamic field of translational cancer research.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25154812 DOI: 10.1038/nrc3820
Source DB: PubMed Journal: Nat Rev Cancer ISSN: 1474-175X Impact factor: 60.716